SCHEMBL2370157

SCHEMBL2370157

O=C1CC=CC2=C1CC(Br)CCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7503939 0.87
SCHEMBL2369445 0.87
SCHEMBL28760196 0.80
SCHEMBL6696358 0.74 ALDH1A1 (0.30)
SCHEMBL1516177 0.74 ALDH1A1 (0.30)
SCHEMBL7996503 0.72 ALDH1A1 (0.31)
SCHEMBL7502449 0.68 ESR2 (0.38)
SCHEMBL2914988 0.67
SCHEMBL8635279 0.64 HCAR2 (0.33)
SCHEMBL9489849 0.63 DAO (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011107494-A1 NOVEL AROMATIC GLYCOSIDE DERIVATIVES, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND THE USE THEREOF SANOFI (FR) 2011-09-09 WO disclosed
EP-0673248-A1 POTASSIUM CHANNEL ACTIVATORS FOR USE IN THERAPY SMITHKLINE BEECHAM PLC (GB) 1995-09-27 EP disclosed
WO-1994013292-A1 POTASSIUM CHANNEL ACTIVATORS FOR USE IN THERAPY SMITHKLINE BEECHAM PLC (GB) 1994-06-23 WO disclosed